Publications by authors named "Radhika Walling"

Claim this Profile
B
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, Fei Shen, Christopher Chitambar, Radhika Walling

J Clin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.
Greg A Durm, Salma K Jabbour, Sandra K Althouse, Ziyue Liu, Ahad A Sadiq, Radhika V Walling

Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Milan Radovich, Guanglong Jiang, Bradley A Hancock, Christopher Chitambar, Rita Nanda, Radhika Walling

JAMA Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer.
Matthew D Galsky, Amir Mortazavi, Matthew I Milowsky, Saby George, Sumati Gupta, Radhika Walling

J Clin Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on myelodysplastic syndromes: new approaches to classification and therapy.
Amelia A Langston, Radhika Walling, Elliott F Winton

Semin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis